TOR1AIP1 and muscular dystrophy: In this study, we established an in vitro model of LAP1B-associated muscular dystrophy by using MyoD-induced myoconversion of patient-derived fibroblasts in order to gain new insights into the molecular mechanisms underlying the pathology.